Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net income $ 1,444,295 $ 804,710
Adjustments to reconcile net income to net cash provided by operating activities:    
Goodwill impairment 0 256,649
Depreciation and amortization 248,688 269,112
Loss on extinguishment of debt 0 22,538
Loss (gain) on unrealized foreign exchange and other (13,339) (1,187)
Asset impairment charges 842 2,581
Stock-based compensation expense 84,146 85,003
Gain on sale of business (4,422) 0
Settlement of treasury lock agreement 0 (21,518)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable (101,134) (128,793)
Inventories (146,375) (18,208)
Other assets (72,138) (29,271)
Accounts payable 30,952 41,239
Deferred system revenue (3,775) 54,035
Deferred service revenue 10,076 7,574
Other liabilities 241,586 (18,460)
Net cash provided by operating activities 1,719,402 1,326,004
Cash flows from investing activities:    
Proceeds from sale of assets 1,855 0
Proceeds from sale of business 16,833 0
Business acquisitions, net of cash acquired 0 (78,600)
Capital expenditures (176,252) (110,885)
Purchases of available-for-sale securities (795,124) (564,655)
Proceeds from sale of available-for-sale securities 125,774 104,770
Proceeds from maturity of available-for-sale securities 418,447 491,269
Purchases of trading securities (83,866) (68,657)
Proceeds from sale of trading securities 84,919 72,619
Proceeds from other investments 614 1,086
Net cash used in investing activities (406,800) (153,053)
Cash flows from financing activities:    
Proceeds from issuance of debt, net of issuance costs 40,343 742,004
Proceeds from revolving credit facility 0 250,000
Repayment of debt (70,000) (996,033)
Common stock repurchases (638,830) (829,084)
Payment of dividends to stockholders (420,086) (389,659)
Issuance of common stock 26,356 25,285
Tax withholding payments related to vested and released restricted stock units (42,819) (40,733)
Payment of contingent consideration payable 0 (60)
Net cash used in financing activities (1,105,036) (1,238,280)
Effect of exchange rate changes on cash and cash equivalents 10,175 (4,490)
Net increase (decrease) in cash and cash equivalents 217,741 (69,819)
Cash and cash equivalents at beginning of period 1,234,409 1,015,994
Cash and cash equivalents at end of period 1,452,150 946,175
Supplemental cash flow disclosures:    
Income taxes paid 214,606 172,820
Interest paid 116,976 114,662
Non-cash activities:    
Contingent consideration (receivable) payable - financing activities (8,570) 6,128
Dividends payable - financing activities 1,982 4,578
Unsettled common stock repurchase - financing activities 6,000 0
Accrued debt issuance costs - financing activities 0 193
Accrued purchases of land, property and equipment - investing activities $ 24,392 $ 17,137